Amphastar Pharma (AMPH) Tops Q2 EPS by 22c

August 8, 2016 5:14 PM EDT
Get Alerts AMPH Hot Sheet
Trade AMPH Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Amphastar Pharma (NASDAQ: AMPH) reported Q2 EPS of $0.23, $0.22 better than the analyst estimate of $0.01. Revenue for the quarter came in at $68 million versus the consensus estimate of $62.1 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment